Skip to main content
GutCited

Vitamin D 관련 Irritable Bowel Syndrome (IBS)

C

Limited studies suggest vitamin D supplementation may improve IBS symptoms, particularly in deficient individuals. Mechanism via VDR-mediated immune modulation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

결론

Limited studies suggest vitamin D supplementation may improve IBS symptoms, particularly in deficient individuals. Mechanism via VDR-mediated immune modulation.

Key Study Findings

Review
Early Evidence Indicates Vitamin D Improves Symptoms of Irritable Bowel Syndrome: Nursing Implications and Future …
Dose: None vs: None Outcome: IBS symptom improvement with vitamin D supplementation 효과: None None

대상 집단: individuals with irritable bowel syndrome

Systematic Review
Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews …
Dose: None vs: Various Outcome: IBS symptom improvement 효과: Probiotics abdominal pain RR 4.04 (2.36-6.92) None

대상 집단: Adult IBS patients

Meta-Analysis Double-blind
The effects of vitamin D intake and status on symptom severity and quality-of-life in adults …
Dose: 3,000 IU daily to 50,000 IU bi-weekly vs: Placebo Outcome: IBS symptom severity and quality of life 효과: MD 20.33 ng/mL [12.91, 27.74] for 25(OH)D; QoL 3.1 None

대상 집단: Adults with IBS and deficient/insufficient vitamin D

Review
Modifiable risk factors associated with the risk of developing Parkinson's disease: a critical review.
Dose: None vs: None Outcome: Risk of developing Parkinson's disease 효과: None None

대상 집단: General population (narrative review of PD risk factors)

Review
Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do?
Dose: None vs: None Outcome: Micronutrient deficiency management in pediatric IBD 효과: None None

대상 집단: Children with inflammatory bowel disease (review)

Review
Vitamin D in Irritable Bowel Syndrome: Exploring Its Role in Symptom Relief and Pathophysiology.
Dose: None vs: None Outcome: IBS symptom relief and pathophysiology modulation 효과: None None

대상 집단: Patients with irritable bowel syndrome (review)

Key Statistics

3

연구

400

참여자

Positive

C

등급

Referenced Papers

Scandinavian journal of … 2025
Journal of gastroenterology … 2023 16 인용
World journal of … 2023 9 인용
Journal of gastroenterology … 2022 29 인용
The journal of … 2020 294 인용
Current gastroenterology reports 2017 157 인용
World journal of … 2016 238 인용
Clinics in dermatology 2016 19 인용
World journal of … 2015 62 인용
European journal of … 2012 225 인용
Inflammatory bowel diseases 2012 224 인용
The Cochrane database … 2012 130 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
600-800 IU/day (RDA)
ibdsupport:
1,000-4,000 IU/day (target serum 25(OH)D >30 ng/mL)
deficiencycorrection:
50,000 IU/week for 8 weeks, then 1,000-4,000 IU/day maintenance

상한량: 4,000 IU/day (100 mcg); higher doses under medical supervision only

연구에서 사용된 용량

용량 기간 효과 N
None -- Positive --
None -- Positive --
3,000 IU daily to 50,000 IU bi-weekly -- Positive --
None -- Mixed --
None -- Neutral --
None -- Positive --
None -- Positive --
None -- Positive 240

권장 복용 시간: With a meal containing fat for better absorption

Safety & Side Effects

보고된 부작용

  • Hypercalcemia at very high doses (nausea, vomiting, weakness, confusion)
  • Kidney stones with excessive long-term supplementation
  • Constipation
  • Metallic taste

알려진 상호작용

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)
  • Statins (vitamin D may affect statin metabolism)

일일 최대 섭취 허용량: 4,000 IU/day (100 mcg); higher doses under medical supervision only

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Vitamin D help with Irritable Bowel Syndrome (IBS)?
Based on 3 studies with 400 participants, there is limited but promising evidence that Vitamin D may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is C (Some Evidence).
How much Vitamin D should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 600-800 IU/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness, confusion), Kidney stones with excessive long-term supplementation, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 3 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.